Vita Dolžan
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 20
- Biological Psychiatry top 5%
-
- Diabetes Treatment and Management 12
- Rheumatology top 2%
-
- Occupational and environmental lung diseases 35
-
- Acute Lymphoblastic Leukemia research 18
-
- Glutathione Transferases and Polymorphisms 13
- Extracellular vesicles in disease 12
-
- Parkinson's Disease Mechanisms and Treatments 12
-
- Carcinogens and Genotoxicity Assessment 11
- Co-authors
- Katja GoričarAndrej JanežPetra Bohanec GrabarJanez JazbecViljem KovačJasna KlenKatja BreskvarMojca Jensterle
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (4 papers)PLoS ONE (2 papers)
- Partner nations
- SloveniaItalyUnited States
In The Last Decade
Vita Dolžan
202 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Pharmacology 446
- Biological Psychiatry 91
- Endocrinology, Diabetes and Metabolism 505
- Rheumatology 381
- Pediatrics, Perinatology and Child Health 404
Countries citing papers authored by Vita Dolžan
This map shows the geographic impact of Vita Dolžan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vita Dolžan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vita Dolžan more than expected).
Fields of papers citing papers by Vita Dolžan
This network shows the impact of papers produced by Vita Dolžan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vita Dolžan. The network helps show where Vita Dolžan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vita Dolžan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 19 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 19 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 13 | |
| 15 | 2019 | 8 | |
| 16 | 2018 | 9 | |
| 17 | Homologous recombination repair polymorphisms and the risk for osteosarcoma | 2015 | 2 |
| 18 | 2013 | 14 | |
| 19 | 2009 | 27 | |
| 20 | GENETIC POLYMORPHISM OF CYTOCHROMES P450 2C9 AND 2C19 IN SLOVENIAN POPULATION | 2003 | 20 |
About Vita Dolžan
Vita Dolžan is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 210 papers that have together received 3.7k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (35 papers), Pharmacogenetics and Drug Metabolism (20 papers), Acute Lymphoblastic Leukemia research (18 papers), Glutathione Transferases and Polymorphisms (13 papers), Diabetes Treatment and Management (12 papers), Parkinson's Disease Mechanisms and Treatments (12 papers), Extracellular vesicles in disease (12 papers) and Carcinogens and Genotoxicity Assessment (11 papers). The work is most often cited by research in Pharmacology (446 citations), Biological Psychiatry (91 citations) and Endocrinology, Diabetes and Metabolism (505 citations). Vita Dolžan has collaborated with scholars based in Slovenia, Italy and United States. Frequent co-authors include Katja Goričar, Andrej Janež, Petra Bohanec Grabar, Janez Jazbec, Viljem Kovač, Jasna Klen, Katja Breskvar, Mojca Jensterle, Iztok Grabnar and D Logar. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.